Mittelbiberach
Germany
64
2022-10-20
The entities that hold a legal rights for patent applications filed by inventor SIEGER Peter:
Peter SIEGER from Mittelbiberach, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
SOLID FORMS OF A GLYT1 INHIBITOR
#2 | 2021-10-21Polymorphs
#3 | 2020-11-05Solid forms of a GlyT1 inhibitor
#4 | 2020-03-19ADMINISTRATION OF ETHYL 3-[(2-{[4-(HEXYLOXYCARBONYL-AMINOIMINOMETHYL)PHENYL-AMINO]METHYL}-1-METHYL-1H-BENZIMIDAZOL-5-CARBONYL)PYRIDIN-2-YLAMINO]PROPIONATE
#5 | 2020-02-20Polymorphs
#6 | 2019-08-01POLYMORPHS
#7 | 2019-08-01ADMINISTRATION OF ETHYL 3-[(2-{[4-(HEXYLOXYCARBONYL-AMINOIMINOMETHYL)PHENYL-AMINO]METHYL}-1-METHYL-1H-BENZIMIDAZOL-5-CARBONYL)PYRIDIN-2-YLAMINO]PROPIONATE
#8 | 2018-08-09ADMINISTRATION OF ETHYL 3-[(2-{[4-(HEXYLOXYCARBONYL-AMINOIMINOMETHYL)PHENYL-AMINO]METHYL}-1-METHYL-1H-BENZIMIDAZOL-5-CARBONYL)PYRIDIN-2-YLAMINO]PROPIONATE
#9 | 2018-04-12Polymorphs
#10 | 2017-01-26Polymorphs
#11 | 2016-05-05Polymorphs
#12 | 2014-12-189-[4-(3-chloro-2-fluoro-phenylamino-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof
#13 | 2014-12-04Polymorphs
#14 | 2014-10-23PROCESS FOR PREPARING NEW TIOTROPIUM SALTS, NEW TIOTROPIUM SALTS AS SUCH AND PHARMACEUTICAL COMPOSITIONS THEREOF
#15 | 2014-10-09Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine
#16 | 2014-01-23Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as a medicament and the preparation thereof
#17 | 2013-08-15Crystalline forms of a hexahydrofuro[3,4-c]quinoline derivative
#18 | 2013-01-319-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5] undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof
#19 | 2013-01-03PROCESS FOR THE SYNTHESIS OF DERIVATIVES OF 3-AMINO-TETRAHYDROFURAN-3-CARBOXYLIC ACID AND USE THEREOF AS MEDICAMENTS
#20 | 2012-11-22POLYMORPHS
#21 | 2012-08-23Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
#22 | 2012-06-078-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals
#23 | 2012-05-24Salt forms of a xanthine compound
#24 | 2012-02-23Salts and hydrates of 4-[(3-chloro-4-fluoro-phenyl)amino]-6-(cis-4--cyclohexan-1-yloxy)-7-methoxy-quinazoline, their use as a medicament and the preparation thereof
#25 | 2010-12-30CRYSTALLINE HYDRATE OF BETAMIMETIKA AND USE AS MEDICAMENT THEREOF
#26 | 2010-12-16PROCESS FOR THE SYNTHESIS OF DERIVATIVES OF 3-AMINO-TETRAHYDROFURAN-3-CARBOXYLIC ACID AND USE THEREOF AS MEDICAMENTS
#27 | 2010-11-04Crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide
#28 | 2010-09-02SINGLE ENANTIOMER BETA-AGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THE USE THEREOF AS MEDICATION
#29 | 2009-12-24New Salts and Crystalline Salt Forms of an Indolinone Derivative
#30 | 2009-12-10Enantiomeric pure beta agonists, manufacturing and use as a medicaments thereof
#31 | 2009-05-28Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
#32 | 2009-02-12Physiologically acceptable salts of 3--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
#33 | 2009-01-29Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
#34 | 2008-10-02BENZOYLGUANIDINE SALT AND HYDRATES THEREOF
#35 | 2008-05-223-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament
#36 | 2008-03-27(R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1- (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition
#37 | 2008-03-20Enantiomerically pure beta agonists, manufacturing and use thereof
#38 | 2008-01-31BENZOYLGUANIDINE SALT AND HYDRATES THEREOF
#39 | 2007-11-08POLYMORPHS
#40 | 2007-10-25Enantiomeric pure β agonists, manufacturing and use as a medicament thereof
#41 | 2007-08-30Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
#42 | 2007-05-03(R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition
#43 | 2007-02-08Powdered Medicaments Containing A Tiotropium Salt and Salmeterol Xinafoate
#44 | 2007-02-01Process for preparing amino crotonyl compounds
#45 | 2007-02-018-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals
#46 | 2007-02-01Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments
#47 | 2007-01-30(R) 2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1 (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition
#48 | 2006-12-21Process For Preparing New Tiotropium Salts, New Tiotropium Salts As Such and Pharmaceutical Compositions Thereof
#49 | 2006-12-07Polymorphs of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H- benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
#50 | 2006-11-163-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
#51 | 2006-11-02Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
#52 | 2006-10-103-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
#53 | 2006-08-31Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
#54 | 2006-02-16Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
#55 | 2005-12-01Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
#56 | 2005-10-203-[(2-{[4-(hexyloxycarbonylaminoiminomethyl)phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as medicament
#57 | 2005-06-30Crystalline anhydrate with anticholinergic efficacy
#58 | 2005-06-21Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
#59 | 2005-06-16Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
#60 | 2005-05-05Novel tiotropium salts, process for the preparation and pharmaceutical compositions thereof
#61 | 2005-04-21Process for preparing amino crotonyl compounds
#62 | 2005-03-22Meloxicam for oral administration
#63 | 2005-02-24Benzoylguanidine salt and hydrates thereof
#64 | 2005-01-13Powder formulations containing tiotropium suitable for inhalation
14676 ⎘